Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Anastrazole-D12; Anastrol-D12; Arimidex-D12
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 95 %
Hazard Compound
No -Refer MSDS for accurate information
Anastrozole-d12 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Anastrozole-d12 usage and description
Anastrozole D12 is a medication used to treat breast cancer in postmenopausal women. It is a type of aromatase inhibitor that works by blocking the production of estrogen in the body, which can slow or stop the growth of certain types of breast cancer that require estrogen to grow. Anastrozole D12 is typically taken in tablet form once a day, with or without food.
Chemically, Anastrozole D12 is a nonsteroidal aromatase inhibitor that binds to the active site of the aromatase enzyme. This prevents the enzyme from converting androgens (male hormones) into estrogen (female hormone) in peripheral tissues. As a result, the levels of estrogen in the body decrease, which can help to slow or stop the growth of hormone receptor-positive breast cancer cells.
Anastrozole D12 is typically prescribed for women who have already gone through menopause and have been diagnosed with early-stage or advanced breast cancer that is hormone receptor-positive. It is not suitable for use in premenopausal women or men. Additionally, Anastrozole D12 may cause side effects such as hot flashes, joint pain, fatigue, and mood changes. Patients should consult with their healthcare provider to determine if Anastrozole D12 is right for them and to discuss any potential side effects or interactions with other medications.
